作者:Wen-Chung Shieh、Joe McKenna、Joseph A. Sclafani、Song Xue、Michael Girgis、James Vivelo、Branko Radetich、Kapa Prasad
DOI:10.1021/op800136f
日期:2008.11.21
We have designed and developed an alternative synthesis for the manufacturing of a triad of Flt3 kinase inhibitors (AST487, ATH686, and AUZ454) to support clinical assessments of patients with Flt3-dependent tumor diseases. The new synthesis is convergent, environmentally friendly, practical, and safe and requires no chromatographic purification.
我们已经设计和开发了一种替代合成方法,用于生产Flt3激酶抑制剂三联体(AST487,ATH686和AUZ454),以支持对Flt3依赖性肿瘤疾病患者的临床评估。新的合成方法具有收敛性,环境友好性,实用性和安全性,并且不需要色谱纯化。